Aperçu gratuit du livre Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Fi
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Fi
Création :
United United States Congress House Committe
bvseo_sdk, dw_cartridge, 18.2.0, p_sdk_3.2.0
CLOUD, getAggregateRating, 10ms
reviews, product
bvseo-msg: Unsuccessful GET. status = 'ERROR', msg = 'Not Found.';
5 septembre 2015
35,75 $
Prix en ligne. Les prix et les offres peuvent différer en magasin.
* Offre en vigueur du 28 novembre au 2 décembre 2024 dans les magasins au Canada et à indigo.ca avec tout achat d'au moins 50 $ d’articles admissibles, avant les taxes, mais après les rabais applicables et l’échange de points. Le montant d’achat minimal exclut les cartes-cadeaux, les frais d'abonnement ou de renouvellement à plum+, les frais d’expédition, les produits de la Fondation Indigo pour l'amour de la lecture et les dons faits à celle-ci. La sélection offerte en magasin et en ligne peut varier.
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit/fr-ca/pricing-of-drugs-codeveloped-by-federal-laboratories-and-private-companies-hearing-before-the-subcommittee-on-regulation-business-opportunities-and-technology-of-the-commit/5D7C80F3-4359-406D-AB71-092DAD0B8D15.html5D7C80F3-4359-406D-AB71-092DAD0B8D15
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Pricing Of Drugs Codeveloped By Federal Laboratories And Private Companies: Hearing Before The Subcommittee On Regulation, Business Opportunities, And Technology Of The Commit
Pricing of Drugs Codeveloped by Federal Laboratories and Private Companies: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Fi